Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

Rigaku

トプコン

マニー

NIDEC SANKYO CORPORATION　

Aichi Tokei Denki

Fujipream

Citizen Holdings

TOKYO SEIMITSU

Hitachi Medical

ONO SOKKI

大和製衡

日東精工

TOKYO KEIKI

メディキット

タムロン

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

日本セラミック etc.

日本セラミック etc.

日本セラミック etc.

Hitachi Zosen etc.

ROHM

Financial Indicator Details: メディキット (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: メディキット (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	13.04% (-5.08%)	13.56% (-9.48%)	15.31% (-5.79%)	14.38% (1.19%)	13.08% (0.27%)
C/F margin (Industry Average)	19.03% (4.61%)	21.05% (5.96%)	20.41% (6.03%)	17.42% (6.39%)	18.07% (6.49%)
ROA (Industry Average)	5.21% (-3.87%)	5.43% (-4.13%)	6.19% (-2.15%)	5.65% (0.83%)	4.94% (0.49%)
ROE (Industry Average)	6.07% (-9.94%)	6.33% (-25.68%)	7.19% (8.95%)	6.57% (-16.23%)	5.67% (2.54%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	4.87% (-0.46%)	5.65% (-13.23%)	5.39% (1.39%)	4.33% (98.25%)
Sales growth (Industry Average)	- (-)	5.16% (-13.10%)	6.25% (16.93%)	2.51% (6.11%)	-0.96% (-1.65%)
Net profit growth (Industry Average)	- (-)	9.34% (-19.19%)	19.96% (194.08%)	-3.69% (-44.77%)	-9.94% (-9.00%)
Operating C/F growth (Industry Average)	- (-)	16.32% (125.18%)	2.97% (25.49%)	-12.46% (9.71%)	2.69% (232.01%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	85.83% (55.35%)	85.75% (54.43%)	86.01% (53.76%)	85.92% (55.27%)	87.12% (55.38%)
Liquidity ratio (Industry Average)	869.56% (259.99%)	880.15% (250.69%)	886.51% (276.19%)	843.94% (285.74%)	1,039.96% (300.76%)
C/F ratio current liabilities (Industry Average)	104.66% (369.78%)	96.65% (400.56%)	100.58% (255.68%)	126.22% (2,833.16%)	103.88% (230.73%)
Quick ratio (Industry Average)	768.26% (173.18%)	789.15% (169.67%)	805.87% (186.16%)	755.02% (196.65%)	904.32% (201.15%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	90.45day (89.35day)	88.88day (99.94day)	91.74day (90.85day)	90.12day (92.99day)	89.66day (97.80day)
Inventory turnover (Industry Average)	50.14day (69.13day)	44.46day (81.63day)	38.50day (89.49day)	46.92day (71.12day)	46.06day (82.23day)
Payable turnover (Industry Average)	35.77day (40.66day)	33.78day (55.57day)	35.61day (51.52day)	42.32day (45.05day)	37.34day (47.38day)
Working capita turnover (Industry Average)	104.82day (117.82day)	99.57day (126.00day)	94.63day (128.82day)	94.72day (119.06day)	98.39day (132.65day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	- (44.01%)	- (19.29%)	- (-2.79%)	- (20.66%)
Dividend Yield (Industry Average)	- (3.25%)	- (1.41%)	- (1.25%)	- (1.61%)	- (1.57%)
PER (Industry Average)	- (-8.47%)	- (25.87%)	- (21.27%)	- (13.28%)	- (22.53%)
PBR (Industry Average)	- (0.81%)	- (1.18%)	- (1.36%)	- (1.21%)	- (1.24%)
PCFR (Industry Average)	- (6.33%)	- (8.84%)	- (7.36%)	- (36.13%)	- (10.35%)
PSR (Industry Average)	- (0.56%)	- (0.80%)	- (0.89%)	- (0.79%)	- (1.06%)

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	7.80% (-183.05%)	7.34% (-166,224.70%)	6.74% (-115.20%)	7.22% (-170.94%)	6.73% (-0.03%)
C/F margin (Industry Average)	- (-20.10%)	- (-7.51%)	- (-2.43%)	- (-3.06%)	- (-1.36%)
ROA (Industry Average)	3.72% (-7.87%)	3.56% (-7.01%)	3.39% (-6.26%)	3.67% (-3.03%)	3.32% (-0.36%)
ROE (Industry Average)	4.30% (-16.75%)	4.16% (-17.18%)	3.98% (32.87%)	4.27% (-6.83%)	3.87% (5.45%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	2.16% (-2.96%)	2.00% (-0.43%)	2.36% (-7.17%)	1.81% (12.76%)
Sales growth (Industry Average)	- (-)	5.16% (2.80%)	6.25% (12.49%)	2.51% (6.17%)	-0.96% (26.85%)
Net profit growth (Industry Average)	- (-)	-1.00% (-7,468.65%)	-2.50% (69.28%)	9.90% (7.85%)	-7.73% (-17.35%)
Operating C/F growth (Industry Average)	- (-)	- (-136.40%)	- (1,462.22%)	- (28.50%)	- (141.61%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	86.49% (58.33%)	85.45% (58.27%)	85.10% (56.06%)	85.83% (54.98%)	85.82% (56.81%)
Liquidity ratio (Industry Average)	762.76% (434.78%)	683.69% (290.28%)	656.26% (350.75%)	734.74% (559.70%)	778.41% (461.82%)
C/F ratio current liabilities (Industry Average)	- (45.55%)	- (-120.18%)	- (-7.69%)	- (0.78%)	- (6.87%)
Quick ratio (Industry Average)	719.23% (307.75%)	644.65% (196.10%)	620.31% (235.82%)	688.84% (316.92%)	692.12% (269.66%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	90.45day (88.94day)	88.88day (107.55day)	91.74day (96.21day)	90.12day (91.10day)	89.66day (57.98day)
Inventory turnover (Industry Average)	4.73day (83.89day)	5.41day (63.66day)	5.75day (72.59day)	8.33day (51.80day)	5.48day (39.78day)
Payable turnover (Industry Average)	46.51day (47.68day)	47.58day (56.31day)	52.69day (50.95day)	46.77day (43.94day)	47.33day (26.54day)
Working capita turnover (Industry Average)	48.67day (125.16day)	46.72day (114.90day)	44.81day (117.85day)	51.68day (98.95day)	47.81day (71.23day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	- (49.67%)	- (16.73%)	- (-3.03%)	- (23.13%)
Dividend Yield (Industry Average)	- (0.16%)	- (0.09%)	- (0.08%)	- (0.08%)	- (0.05%)
PER (Industry Average)	- (-287.07%)	- (15.35%)	- (23.93%)	- (28.68%)	- (4.24%)
PBR (Industry Average)	- (0.99%)	- (1.46%)	- (1.64%)	- (1.58%)	- (1.59%)
PCFR (Industry Average)	- (3.52%)	- (0.29%)	- (0.47%)	- (0.82%)	- (0.55%)
PSR (Industry Average)	- (1.31%)	- (1.94%)	- (1.89%)	- (3.03%)	- (4.11%)

Financial Indicator Details: メディキット

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	13.04%	13.56%	15.31%	14.38%	13.08%
C/F margin	19.03%	21.05%	20.41%	17.42%	18.07%
ROA	5.21%	5.43%	6.19%	5.65%	4.94%
ROE	6.07%	6.33%	7.19%	6.57%	5.67%
Recurring margin	22.34%	23.93%	26.36%	26.51%	22.51%
EBIT margin	21.80%	22.65%	25.93%	25.64%	21.44%
EBITDA margin	28.78%	28.09%	30.63%	30.10%	26.93%
NOPAT margin	13.08%	13.59%	15.56%	15.38%	12.86%
Sales SG rates	54.48%	54.01%	52.28%	52.22%	55.36%
Sales SG&A rates	24.00%	22.88%	21.96%	21.81%	22.84%
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	6.97%	5.43%	4.70%	4.45%	5.49%
Capital expenditures net sales ratio	-7.72%	-3.65%	-4.24%	-9.34%	-4.97%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	11.70%	9.38%	3.30%	1.70%
Equity growth	-	4.87%	5.65%	5.39%	4.33%
Total assets growth	-	4.98%	5.32%	5.50%	2.90%
Sales growth	-	5.16%	6.25%	2.51%	-0.96%
Net profit growth	-	9.34%	19.96%	-3.69%	-9.94%
Operating C/F growth	-	16.32%	2.97%	-12.46%	2.69%
Recurring profit growth	-	12.65%	17.06%	3.08%	-15.88%
EBIT growth	-	9.25%	21.63%	1.37%	-17.19%
EBITDA growth	-	2.63%	15.88%	0.72%	-11.37%
NOPAT growth	-	9.25%	21.63%	1.37%	-17.19%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	85.83%	85.75%	86.01%	85.92%	87.12%
Liquidity ratio	869.56%	880.15%	886.51%	843.94%	1,039.96%
C/F ratio current liabilities	104.66%	96.65%	100.58%	126.22%	103.88%
Quick ratio	768.26%	789.15%	805.87%	755.02%	904.32%
Fixed ratio	30.16%	27.91%	26.07%	27.57%	25.71%
D/E ratio	-	-	-	-	-
Loan to Value Ratio	-	-	-	-	-
Business investment C/F ratio	-40.56%	-17.35%	-20.77%	-53.64%	-27.51%
Liabilities with interest growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	468.33day	497.44day	512.12day	516.03day	529.95day
Receivables turnover	90.45day	88.88day	91.74day	90.12day	89.66day
Inventory turnover	50.14day	44.46day	38.50day	46.92day	46.06day
Fixed assets turnover	236.27day	218.01day	202.53day	220.14day	216.30day
Total asset turnover	912.41day	910.81day	902.89day	929.17day	965.48day
Payable turnover	35.77day	33.78day	35.61day	42.32day	37.34day
Capital turnover	36.74day	34.93day	32.88day	32.07day	32.38day
Equity turnover	783.18day	781.03day	776.64day	798.42day	841.14day
Working capita turnover	104.82day	99.57day	94.63day	94.72day	98.39day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 15 B	¥ 17 B	¥ 19 B	¥ 19 B	¥ 20 B
Accounts receivable-trade	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
Other Current Assets	¥ 5 B	¥ 5 B	¥ 5 B	¥ 6 B	¥ 6 B
Current Assets	¥ 21 B	¥ 23 B	¥ 25 B	¥ 26 B	¥ 27 B
Tangible Assets	¥ 7 B	¥ 7 B	¥ 7 B	¥ 8 B	¥ 8 B
Intangible Assets	¥ 159 M	¥ 112 M	¥ 65 M	¥ 18 M	¥ 30 M
Investment etc.	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Total Assets	¥ 30 B	¥ 32 B	¥ 34 B	¥ 35 B	¥ 37 B
Current Liabilities	¥ 2 B	¥ 2 B	¥ 2 B	¥ 3 B	¥ 2 B
Fixed Liabilities	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B
Liabilities with interest	-	-	-	-	-
Net Assets	¥ 26 B	¥ 27 B	¥ 29 B	¥ 30 B	¥ 32 B
Capital stock	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Capital surplus etc.	¥ 25 B	¥ 26 B	¥ 28 B	¥ 29 B	¥ 30 B
Liabilities and net assets	¥ 30 B	¥ 32 B	¥ 34 B	¥ 35 B	¥ 37 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 12 B	¥ 12 B	¥ 13 B	¥ 14 B	¥ 13 B
Cost of Sales	¥ 6 B	¥ 7 B	¥ 7 B	¥ 7 B	¥ 7 B
Gross profit	¥ 5 B	¥ 5 B	¥ 6 B	¥ 6 B	¥ 6 B
Other income	¥ 230 M	¥ 181 M	¥ 107 M	¥ 97 M	¥ 114 M
SG&A	¥ 2 B	¥ 2 B	¥ 3 B	¥ 3 B	¥ 3 B
Other expenses	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Net income	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 1 B
Operating income	¥ 2 B	¥ 2 B	¥ 3 B	¥ 3 B	¥ 3 B
Ordinary Income	¥ 2 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
EBITDA	¥ 3 B	¥ 3 B	¥ 4 B	¥ 4 B	¥ 3 B
Income before income taxes	¥ 2 B	¥ 2 B	¥ 3 B	¥ 3 B	¥ 3 B
Depreciation	¥ 860 M	¥ 704 M	¥ 647 M	¥ 629 M	¥ 768 M
R&D expenses	-	-	-	-	-
Income taxes	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Investment CF	¥ -8 B	¥ -2 B	¥ -1 B	¥ -1 B	¥ -684 M
Financial CF	¥ -467 M	¥ -468 M	¥ -467 M	¥ -467 M	¥ -514 M
Foreign Exchange Effects	¥ -4 M	¥ 313 K	¥ -785 K	¥ -29 M	¥ 11 M
Net Change in Cash	¥ -7 B	¥ -648 M	¥ 659 M	¥ 638 M	¥ 1 B
Free CF	¥ -6 B	¥ -180 M	¥ 1 B	¥ 1 B	¥ 1 B
Capital expenditures	¥ -952 M	¥ -473 M	¥ -584 M	¥ -1 B	¥ -695 M
Cash dividends paid	¥ -467 M	¥ -468 M	¥ -467 M	¥ -467 M	¥ -514 M
Repayment loans	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -467 M	¥ -467 M	¥ -467 M	¥ -467 M	¥ -514 M
Net income	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 1 B
Purchase of treasury stock	¥ -88 K	-	-	-	-
Other Change in Stockholders Equity	¥ -2 K	-	-	¥ 1 K	¥ -60 M
Other Change in Net Assets	¥ -17 M	¥ -746 K	¥ -72 M	¥ 15 M	¥ 85 M
Net Change in Net Assets	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B

Financial Indicator Details: メディキット

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	7.80%	7.34%	6.74%	7.22%	6.73%
C/F margin	-	-	-	-	-
ROA	3.72%	3.56%	3.39%	3.67%	3.32%
ROE	4.30%	4.16%	3.98%	4.27%	3.87%
Recurring margin	11.81%	11.28%	10.26%	10.75%	9.18%
EBIT margin	11.54%	10.87%	10.12%	10.68%	8.66%
EBITDA margin	11.91%	11.23%	10.47%	11.02%	8.86%
NOPAT margin	6.92%	6.52%	6.07%	6.41%	5.19%
Sales SG rates	71.23%	72.32%	73.85%	75.08%	76.69%
Sales SG&A rates	20.27%	19.42%	18.63%	18.38%	18.76%
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	0.37%	0.35%	0.34%	0.33%	0.19%
Capital expenditures net sales ratio	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	7.26%	3.34%	2.80%	-2.72%
Equity growth	-	2.16%	2.00%	2.36%	1.81%
Total assets growth	-	3.41%	2.42%	1.50%	1.82%
Sales growth	-	5.16%	6.25%	2.51%	-0.96%
Net profit growth	-	-1.00%	-2.50%	9.90%	-7.73%
Operating C/F growth	-	-	-	-	-
Recurring profit growth	-	0.48%	-3.30%	7.34%	-15.40%
EBIT growth	-	-0.93%	-1.05%	8.18%	-19.68%
EBITDA growth	-	-0.86%	-0.93%	7.92%	-20.38%
NOPAT growth	-	-0.93%	-1.05%	8.18%	-19.68%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	86.49%	85.45%	85.10%	85.83%	85.82%
Liquidity ratio	762.76%	683.69%	656.26%	734.74%	778.41%
C/F ratio current liabilities	-	-	-	-	-
Quick ratio	719.23%	644.65%	620.31%	688.84%	692.12%
Fixed ratio	7.44%	7.29%	7.06%	6.82%	6.61%
D/E ratio	-	-	-	-	-
Loan to Value Ratio	-	-	-	-	-
Business investment C/F ratio	-	-	-	-	-
Liabilities with interest growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	304.05day	310.13day	301.64day	302.50day	297.11day
Receivables turnover	90.45day	88.88day	91.74day	90.12day	89.66day
Inventory turnover	4.73day	5.41day	5.75day	8.33day	5.48day
Fixed assets turnover	49.28day	46.92day	43.65day	42.08day	41.93day
Total asset turnover	765.48day	752.72day	725.61day	718.41day	738.60day
Payable turnover	46.51day	47.58day	52.69day	46.77day	47.33day
Capital turnover	36.74day	34.93day	32.88day	32.07day	32.38day
Equity turnover	662.13day	643.24day	617.52day	616.61day	633.93day
Working capita turnover	48.67day	46.72day	44.81day	51.68day	47.81day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 10 B	¥ 11 B	¥ 11 B	¥ 11 B	¥ 11 B
Accounts receivable-trade	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
Other Current Assets	¥ 3 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 5 B
Current Assets	¥ 14 B	¥ 15 B	¥ 15 B	¥ 16 B	¥ 16 B
Tangible Assets	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Intangible Assets	¥ 76 M	¥ 54 M	¥ 32 M	¥ 10 M	¥ 9 M
Investment etc.	¥ 9 B	¥ 9 B	¥ 10 B	¥ 9 B	¥ 10 B
Total Assets	¥ 25 B	¥ 26 B	¥ 27 B	¥ 27 B	¥ 28 B
Current Liabilities	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Fixed Liabilities	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Liabilities with interest	-	-	-	-	-
Net Assets	¥ 22 B	¥ 22 B	¥ 23 B	¥ 23 B	¥ 24 B
Capital stock	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Capital surplus etc.	¥ 21 B	¥ 21 B	¥ 22 B	¥ 22 B	¥ 23 B
Liabilities and net assets	¥ 25 B	¥ 26 B	¥ 27 B	¥ 27 B	¥ 28 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 12 B	¥ 12 B	¥ 13 B	¥ 14 B	¥ 13 B
Cost of Sales	¥ 8 B	¥ 9 B	¥ 10 B	¥ 10 B	¥ 10 B
Gross profit	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
Other income	¥ 424 M	¥ 403 M	¥ 390 M	¥ 614 M	¥ 659 M
SG&A	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Other expenses	¥ 508 M	¥ 520 M	¥ 496 M	¥ 514 M	¥ 353 M
Net income	¥ 962 M	¥ 952 M	¥ 929 M	¥ 1 B	¥ 942 M
Operating income	¥ 1 B	¥ 1 B	¥ 1 B	¥ 921 M	¥ 636 M
Ordinary Income	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
EBITDA	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Income before income taxes	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Depreciation	¥ 45 M	¥ 46 M	¥ 47 M	¥ 47 M	¥ 27 M
R&D expenses	-	-	-	-	-
Income taxes	¥ 491 M	¥ 485 M	¥ 474 M	¥ 490 M	¥ 270 M
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	-	-	-	-	-
Investment CF	-	-	-	-	-
Financial CF	-	-	-	-	-
Foreign Exchange Effects	-	-	-	-	-
Net Change in Cash	-	-	-	-	-
Free CF	-	-	-	-	-
Capital expenditures	-	-	-	-	-
Cash dividends paid	-	-	-	-	-
Repayment loans	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -467 M	¥ -467 M	¥ -467 M	¥ -467 M	¥ -514 M
Net income	¥ 962 M	¥ 952 M	¥ 929 M	¥ 1 B	¥ 942 M
Purchase of treasury stock	¥ -88 K	-	-	-	-
Other Change in Stockholders Equity	¥ -1 K	-	-	-	-
Other Change in Net Assets	¥ -11 M	¥ -577 K	¥ -3 M	¥ -1 M	¥ 6 M
Net Change in Net Assets	¥ 482 M	¥ 484 M	¥ 458 M	¥ 552 M	¥ 434 M

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: メディキット (Annual )

Statement Type

Annual : メディキット

First quarter : メディキット

Second quarter : メディキット

Third quarter : メディキット

Analysis Menu

Outline : メディキット

Statement : メディキット

Rating : メディキット

Indicator : メディキット

Download : メディキット

Industry Comparison Ranking

Precision Instruments - EDIUNET Industry Rankings

Precision Instruments - EDIUNET Credit Rating

Precision Instruments - EDIUNET Industry Avg

Comparison with a neighboring company

Tokyo - EDIUNET Prefectures

Tokyo文京区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/15	シグマ光機	BBB	2013-11-30 (Q2)
1/15	RORZE	B→BB	2013-11-30 (Q3)
1/9	スター精密	BB	2013-11-30 (Q3)
1/7	マニー	AA	2013-11-30 (Q1)
12/13	インスペック	C	2013-10-31 (Q2)
12/5	三井ハイテック	A→AA	2013-10-31 (Q3)
12/5	アルチザネットワークス	BB→BBB	2013-10-31 (Q1)
11/14	asahi intecc	BBB→A	2013-09-30 (Q1)
11/14	黒田精工	B→CCC	2013-09-30 (Q2)
11/14	Precision Sysem Science	CCC→BBB	2013-09-30 (Q1)

EDIUNET Investment News (Precision Instruments)

1/15 Precision Instruments (シグ..

1/9 Precision Instruments (スタ..

1/7 Precision Instruments (マニ..

12/13 Precision Instruments (イン..

12/5 Precision Instruments (三井..

11/14 Precision Instruments (asahi..

11/13 Precision Instruments (OVAL:..

11/12 Precision Instruments (SEIKO..

11/11 Precision Instruments (MORIT..

11/8 Precision Instruments (オリ..

Company Information

Ticker	Market	Industry	Month	report	Rating
メディキット	7749	OSE JASDAQ	Precision Instruments	3	Annual	AA

Related Company

RHYTHM WATCH (Sales ¥ 32 B)

TOKYO SEIMITSU (Sales ¥ 51 B)

エスペック (Sales ¥ 30 B)

Fujipream (Sales ¥ 11 B)

KOKUSAI (Sales ¥ 10 B)

タムロン (Sales ¥ 64 B)

NIDEC TOSOK (Sales ¥ 31 B)

ＭＵＴＯＨホールディングス (Sales ¥ 17 B)

日東精工 (Sales ¥ 25 B)

NIDEC SANKYO CORPORATION　 (Sales ¥ 81 B)

SEIKO HOLDINGS (Sales ¥ 283 B)

マニー (Sales ¥ 9 B)

ONO SOKKI (Sales ¥ 11 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .